We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Glaukos
GKOS
$10.4B
| $8.67M | 0.02% |
+175,000
| New | +$7.69M |
|
552
Velocity Financial
VEL
$723M
| $8.63M | 0.02% |
1,719,325
+19,325
| +1% | +$85.2K |
|
553
Comstock Resources
CRK
$3.93B
| $8.59M | 0.02% |
1,962,200
-1,737,800
| -47% | -$9.21M |
|
554
Live Nation Entertainment
LYV
$42.7B
| $8.56M | 0.02% |
158,914
-4,420
| -3% | -$228K |
|
555
Carnival Corporation Ltd
CCL
$39B
| $8.53M | 0.02% |
561,800
+35,700
| +7% | +$552K |
|
556
Incyte
INCY
$24.4B
| $8.47M | 0.02% |
94,402
-62,600
| -40% | -$6.04M |
|
557
NRG Energy
NRG
$25.5B
| $8.43M | 0.02% |
274,220
-8,800
| -3% | -$291K |
|
558
Host Hotels & Resorts
HST
$16.1B
| $8.37M | 0.02% |
775,433
-25,600
| -3% | -$283K |
|
559
Equifax
EFX
$21.5B
| $8.33M | 0.02% |
53,100
-84,400
| -61% | -$13.8M |
|
560
NetApp
NTAP
$36.9B
| $8.26M | 0.02% |
188,400
+22,900
| +14% | +$999K |
|
|
ORTX
561
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $8.22M | 0.02% |
200,000
-100,000
| -33% | -$5.17M |
|
562
Quanta Services
PWR
$101B
| $8.09M | 0.02% |
153,047
+67,900
| +80% | +$3.16M |
|
563
Kymera Therapeutics
KYMR
$8.78B
| $8.08M | 0.02% |
+250,000
| New | +$7.63M |
|
|
DISH
564
DELISTED
DISH Network Corp.
DISH
| $7.99M | 0.02% |
275,165
-422,102
| -61% | -$13.9M |
|
|
CKH
565
DELISTED
Seacor Holdings Inc.
CKH
| $7.85M | 0.02% |
270,000
+80,000
| +42% | +$2.37M |
|
566
Diamondback Energy
FANG
$52.4B
| $7.77M | 0.02% |
257,840
-170,700
| -40% | -$6.5M |
|
|
CTXS
567
DELISTED
Citrix Systems Inc
CTXS
| $7.67M | 0.02% |
55,700
-28,500
| -34% | -$4.07M |
|
568
Wynn Resorts
WYNN
$10.5B
| $7.6M | 0.02% |
105,800
-3,600
| -3% | -$285K |
|
569
AtriCure
ATRC
$2.06B
| $7.58M | 0.02% |
190,000
-110,000
| -37% | -$4.66M |
|
570
Hewlett Packard
HPE
$68.8B
| $7.5M | 0.02% |
800,036
-236,600
| -23% | -$2.26M |
|
571
Jack Henry & Associates
JKHY
$11.1B
| $7.49M | 0.02% |
46,061
+8,713
| +23% | +$1.51M |
|
572
IDEX
IEX
$17.4B
| $7.31M | 0.02% |
40,076
+11,800
| +42% | +$2.04M |
|
573
Sutro Biopharma
STRO
$409M
| $7.29M | 0.02% |
72,500
| – | – |
|
|
BDSI
574
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $7.27M | 0.02% |
1,950,000
| – | – |
|
|
DCPH
575
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $7.23M | 0.02% |
+141,000
| New | +$6.91M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.